No significant difference between ceftriaxone and cefotaxime in the emergence of antibiotic resistance in the gut microbiota of hospitalized patients: A pilot study
Background: Ceftriaxone and cefotaxime share a similar antibacterial spectrum and similar indications but have different pharmacokinetic characteristics. Ceftriaxone is administered once daily and 40% of its clearance is by biliary elimination, whereas cefotaxime requires three administrations per d...
Main Authors: | Benoît Pilmis, Olivier Jiang, Assaf Mizrahi, Jean-Claude Nguyen Van, Julie Lourtet-Hascoët, Olivier Voisin, Erwan Le Lorc’h, Sidonie Hubert, Elodie Ménage, Philippe Azria, Marie-Françoise Borie, Annabelle Mahé, Jean-Jacques Mourad, Eloïse Trabattoni, Olivier Ganansia, Jean-Ralph Zahar, Alban Le Monnier |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-03-01
|
Series: | International Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971221000357 |
Similar Items
-
Chromatographic analysis of immobilized cefotaxime
by: Stirbet Daniela, et al.
Published: (2014-01-01) -
Minimum Inhibitory Concentration of Cefotaxime by E-test Method on Klebsiella in Gorgan
by: H Mahmoudjanlou, et al.
Published: (2012-10-01) -
Evaluation of Efficacy and Tolerability of Cefotaxime and Sulbactam Versus Cefepime and Tazobactam in Patients of Urinary Tract Infection-A Prospective Comparative Study
by: Kamalpreet Kaur, et al.
Published: (2014-11-01) -
Cefotaxime/sulbactam: clinical and pharmacological characteristics
by: Ortenberg E.A., et al.
Published: (2019-12-01) -
Development and Validation of a Successful Microbiological Agar Assay for Determination of Ceftriaxone Sodium in Powder for Injectable Solution
by: Patrícia V. Aléssio, et al.
Published: (2012-06-01)